Cameron Tammy

VP, Finance at Assertio Therapeutics, Inc · on record since Jan 27, 2009

Insider trading activity of Cameron Tammy

Transactions on record: 24; since Jan 29, 2008

Open-market buys: 0

Open-market sells: 7; $807.6K

Companies traded: 1; last filing Sep 2, 2011

Figures computed from official regulatory filings — .

Companies where Cameron Tammy has traded

Assertio Therapeutics, Inc24 tx · $1M · Sep 2, 2011

Track record of Cameron Tammy

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Cameron Tammy

Co-insiders of Cameron Tammy

ANIDO VICENTE JRAssertio Therapeutics, Inc
BERNER BRETAssertio Therapeutics, Inc
BIOVAIL LABORATORIES INCAssertio Therapeutics, Inc
Bukofzer StanAssertio Therapeutics, Inc
BURRILL STEVENAssertio Therapeutics, Inc
CALLAGHAN MICHAEL JAssertio Therapeutics, Inc
DAWES KAREN AAssertio Therapeutics, Inc
DONENBERG PHILIP BAssertio Therapeutics, Inc
FARA JOHN WAssertio Therapeutics, Inc
FOGARTY JAMES PAssertio Therapeutics, Inc
Gosling Matthew MAssertio Therapeutics, Inc
HAMILTON JOHN FAssertio Therapeutics, Inc
HIGGINS ARTHUR JAssertio Therapeutics, Inc
LAVIGNE LOUIS J JRAssertio Therapeutics, Inc
MCKEE WILLIAMAssertio Therapeutics, Inc
Molinelli GavinAssertio Therapeutics, Inc
Moretti August JAssertio Therapeutics, Inc
Pelzel Carl AAssertio Therapeutics, Inc
PROEHL GERALD TAssertio Therapeutics, Inc
Saks Samuel RAssertio Therapeutics, Inc
SAVAGE ROBERT GAssertio Therapeutics, Inc
Schoeneck James AAssertio Therapeutics, Inc
SHELL JOHN NAssertio Therapeutics, Inc
SHELL JOHN WAssertio Therapeutics, Inc
Shively Richard ScottAssertio Therapeutics, Inc
SMITH CRAIG RAssertio Therapeutics, Inc
Srinivas RaoAssertio Therapeutics, Inc
STAPLE PETER DAssertio Therapeutics, Inc
STERN JULIAN NAssertio Therapeutics, Inc
Sweeney Michael MDAssertio Therapeutics, Inc
TANG CAPITAL MANAGEMENT LLCAssertio Therapeutics, Inc
TANG CAPITAL PARTNERS LPAssertio Therapeutics, Inc
TANG KEVIN CAssertio Therapeutics, Inc

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Assertio Therapeutics, IncSecurity delisted	Sep 2, 2011	AwardD (derivative)	37,500	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Sell	-4,487	8.20 USD	$36.8K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Exercise	17,493	3.09 USD	$54.1K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	ExerciseD (derivative)	-1,354	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Sell	-6,579	8.24 USD	$54.2K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Exercise	1,354	1.83 USD	$2.5K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Exercise	4,487	3.09 USD	$13.9K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Sell	-17,493	8.20 USD	$143.4K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	ExerciseD (derivative)	-17,493	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Sell	-1,354	8.20 USD	$11.1K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	ExerciseD (derivative)	-4,487	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	Sell	-17,742	8.36 USD	$148.3K	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	Exercise	18,821	1.83 USD	$34.4K	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	Sell	-30,000	8.61 USD	$258.3K	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	Exercise	17,742	1.83 USD	$32.5K	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	ExerciseD (derivative)	-18,821	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	Exercise	30,000	1.98 USD	$59.4K	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	Sell	-18,821	8.26 USD	$155.5K	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	ExerciseD (derivative)	-30,000	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	ExerciseD (derivative)	-17,742	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 14, 2011	AwardD (derivative)	32,500	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 8, 2010	AwardD (derivative)	70,000	0.00	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 27, 2009	AwardD (derivative)	65,000	0.00	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 29, 2008	AwardD (derivative)	13,000	0.00	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Assertio Therapeutics, IncSecurity delisted	Sep 2, 2011	AwardD (derivative)	37,500	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Sell	-4,487	8.20 USD	$36.8K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Exercise	17,493	3.09 USD	$54.1K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	ExerciseD (derivative)	-1,354	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Sell	-6,579	8.24 USD	$54.2K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Exercise	1,354	1.83 USD	$2.5K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Exercise	4,487	3.09 USD	$13.9K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Sell	-17,493	8.20 USD	$143.4K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	ExerciseD (derivative)	-17,493	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	Sell	-1,354	8.20 USD	$11.1K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 15, 2011	ExerciseD (derivative)	-4,487	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	Sell	-17,742	8.36 USD	$148.3K	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	Exercise	18,821	1.83 USD	$34.4K	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	Sell	-30,000	8.61 USD	$258.3K	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	Exercise	17,742	1.83 USD	$32.5K	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	ExerciseD (derivative)	-18,821	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	Exercise	30,000	1.98 USD	$59.4K	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	Sell	-18,821	8.26 USD	$155.5K	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	ExerciseD (derivative)	-30,000	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	May 13, 2011	ExerciseD (derivative)	-17,742	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 14, 2011	AwardD (derivative)	32,500	0.00 USD	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 8, 2010	AwardD (derivative)	70,000	0.00	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 27, 2009	AwardD (derivative)	65,000	0.00	—	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 29, 2008	AwardD (derivative)	13,000	0.00	—	SEC